Allopurinol
- Product NDC
- 66064-1044
- 11-digit product format
- 660641044
- Labeler code
- 66064
- Product ID
- 66064-1044_4e6cc3bc-acec-4e6f-a19b-0bdaade90429
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Allopurinol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Harman Finochem Limited
- Application
- ANDA214443
- Marketing category
- ANDA
- Marketing start
- 2022-12-01
- Marketing end
- 0000-00-00
- Substance
- ALLOPURINOL
- Active strength
- 300 mg/1
- Pharmacologic classes
- Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 66064-1044-5 | 66064104405 | 100 TABLET in 1 BOTTLE (66064-1044-5) | 100 tablet | 2022-12-01 | 0000-00-00 | No | No | Current |
| 66064-1044-6 | 66064104406 | 500 TABLET in 1 BOTTLE (66064-1044-6) | 500 tablet | 2022-12-01 | 0000-00-00 | No | No | Current |